Niki BioSolutions, Inc. (NIKI) reporting calendar
Niki BioSolutions, Inc. files periodic reports with the SEC as NIKI on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 27 Mar 2026
- Reports on record
- 8
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 27 Mar 2026 | 86 days | 0001213900-26-035484 |
| 20-F | 31 Dec 2024 | 30 Apr 2025 | 120 days | 0001213900-25-037669 |
| 20-F | 31 Dec 2023 | 30 Apr 2024 | 121 days | 0001213900-24-037520 |
| 20-F | 31 Dec 2022 | 28 Apr 2023 | 118 days | 0001213900-23-033525 |
| 20-F | 31 Dec 2021 | 29 Apr 2022 | 119 days | 0001213900-22-022702 |
| 20-F | 31 Dec 2020 | 19 Apr 2021 | 109 days | 0001213900-21-021984 |
| 20-F | 31 Dec 2019 | 29 Apr 2020 | 120 days | 0001213900-20-010347 |
| 20-F | 31 Dec 2018 | 15 Apr 2019 | 105 days | 0001213900-19-006328 |
Source: SEC EDGAR company submissions for CIK 0001734005. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.